The test uses RNA contained in blood to measure the level of the expression of seven genes and provide an assessment of a patient’s risk of having colorectal cancer.
The test, which requires a small sample of blood, was originally developed by GeneNews.
Related Articles on Colorectal Cancer Prevention:
Ohio Gastroenterology Group Provides Free Colonoscopies to Uninsured
American College of Physicians Issues New Guidance for Colorectal Cancer Screening
Kentucky’s Tri-State Gastroenterology Associates to Provide Free Colon Cancer Education Program
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
